维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

19篇 您的检索式：作者名="WESTBY J"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Diagnosis,prevention,and management of delirium:summary of NICE guigance显示文摘	Young J Murthy L Westby M		0，，：	1
	2	Reduced Maximal Inhibition in Phenotypic Susceptibility Assays Indicates that Viral Strains Resistant to the CCR5 Antagonist Maraviroc Utilize Inhibitor-Bound Receptor for Entry显示文摘	Westby M Smith-Burchnell C Mori J	2007	J Virol2007，81，：	1
	3	Determination of the extent of incorporation of a reactive surfactant in polystyrene latex particles via GPC显示文摘	PALLUES A L L WESTBY J	1990	Macromol Chem Macromol Symp1990，3536，：	1
	4	Gas cooling - a worldwide overview显示文摘	Chapman J Westby P Whitman D	1993	Gas Engineering & Management1993，，10：	1
	5	Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-uslng virus reservoir显示文摘	Westby M Lewis M Whitcomb J	2006	J Virol2006，80，10：	1
	6	Diagnosis,prevention,and management of delirium : summary of NICE guidance显示文摘	Young J Murthy L Westby M	2010	BMJ2010，341，：	1
	7	Strategy shifts in leaf physiology, structure and nutrient content between species of high and low rainfall and high and low nutrient habitats 显示文摘	Wright I J Reich P B Westby M	2001	Functional Ecolo- gy2001，15，4：	1
	8	Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry显示文摘	Westby M Smith-Burchnell C Mori J	2007	J Virol2007，81，5：	1
	9	Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1 infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir 显示文摘	Westby M Lewis M Whitcomb J	2006	J Virol2006，80，10：	1
	10	Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise显示文摘	van GUILDER G P WESTBY C M GREINER J J	2007	Hypertension2007，50，：	1
	11	Consumer preferences and fungal and mycotoxin contamination of dried cassava products from Ghana显示文摘	Wareing P W Westby A Gibbs J A	2001	Int J Food Sci Technol2001，36，：	1
	12	Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA(COSMIC trial)显示文摘	Stellbrink HJ van Lunzen J Westby M	2002	AIDS2002，16，15：	1
	13	Emergence of CXCR4- using human immunodeficiency virus type 1 ( HIV-1 ) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir显示文摘	Westby M Lewis M Whitcomb J	2006	J Virol2006，80，10：	1
	14	Diagnosis, prevention, and management of delirium: summary of NICE guidance显示文摘	Young J Murthy L Westby M	2010	BMJ2010，341，：	1
	15	A randomized controlled trial to evaluate the effectiveness of an exercise program in woman with rheumatoid arthritis taking low prednisone显示文摘	Westby MD Berkowitz J Rangno KK	2000	J Rheumatol2000，27，7：	1
	16	Diagnosis,prevention,and management of delirium:summary of NICE guidance显示文摘	Young J Murthy L Westby M	2010	BMJ2010，341，：	1
	17	Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry显示文摘	Westby M Smith-Burchnell C Mori J	2007	J Virol2007，81，5：	1
	18	Effects of interleukin-2 plus highly active antiretroviral therapy kon HIV-1 replication and proviral DNA(COSMIC trial) 显示文摘	Stellbrink HJ van Lunzen J Westby M	2002	AIDS2002，16，11：	1
	19	Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir显示文摘	Westby M Lewis M Whitcomb J	2006	J Virol2006，80，10：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费